Terkko Navigator / -/ Feeds / " ( ( CD59-antigeenit )|( CD59 )|( CD59-antigeeni )|( ( ( Antigeenit )|( Ag )|( Antigeeni "

Cd59 and inflammation regulate Schwann cell development

Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma

Microorganisms, Vol. 9, Pages 1135: Lipoteichoic acid from Staphylococcus aureus Activates the Complement System via C3 Induction and CD55 Inhibition

Lipoteichoic Acid from <em>Staphylococcus aureus</em> Activates the Complement System via C3 Induction and CD55 Inhibition

Protectin DX attenuates IL-1β-induced inflammation via the AMPK/NF-κB pathway in chondrocytes and ameliorates osteoarthritis progression in a rat model.

Protectin DX ameliorates inflammation in sepsis-induced acute lung injury through mediating PPARγ/NF-κB pathway

Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation

Protectin DX promotes the inflammatory resolution via activating COX-2/L-PGDS-PGD₂ and DP₁ receptor in acute respiratory distress syndrome

Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59).

Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59)

Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59).

Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59)

Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration

Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).

Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59)

JCM, Vol. 10, Pages 2580: A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice

Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor

Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones

Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.

Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.

Protectin DX promotes epithelial injury repair and inhibits fibroproliferation partly via ALX/PI3K signalling pathway

Elevated levels of the complement regulator protein CD59 in severe acute pancreatitis.

Elevated levels of the complement regulator protein CD59 in severe acute pancreatitis.

Elevated levels of the complement regulator protein CD59 in severe acute pancreatitis.

Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.

Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.

Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.

Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.

NF-κB and enhancer-binding CREB scaffolded by CBP/p300 regulate CD59 expression to protect cells from complement attack.

Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections

Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol

Hematology Reports, Vol. 14, Pages 172-178: A Splice Site Mutation Associated with Congenital CD59 Deficiency

[ASAP] <italic toggle="yes">In Vitro</italic> Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2

Plasma CD59 Concentrations are Increased in Preeclampsia with Severe Features and Correlate with Laboratory Measures of End-Organ Injury

Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes

Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets

Biomedicines, Vol. 9, Pages 1065: Clostridium Butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host

Lack of Complement Inhibitors in the Outer Intracranial Artery Aneurysm Wall Associates with Complement Terminal Pathway Activation.

Lack of Complement Inhibitors in the Outer Intracranial Artery Aneurysm Wall Associates with Complement Terminal Pathway Activation.

Lack of Complement Inhibitors in the Outer Intracranial Artery Aneurysm Wall Associates with Complement Terminal Pathway Activation.

Double lipoxygenation of polyunsaturated fatty acids of nutritional interest.

Lack of complement inhibitors in the outer intracranial artery aneurysm wall associates with complement terminal pathway activation

Lack of complement inhibitors in the outer intracranial artery aneurysm wall associates with complement terminal pathway activation

Plasma lipidome acts as diagnostic marker and predictor for cyclosporin response in patients with aplastic anemia

Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake

Local Shifts in Inflammatory and Resolving Lipid Mediators in Response to Tendon Overuse

Activation of inflammation and resolution pathways of lipid mediators in synovial fluid from patients with severe rheumatoid arthritis compared with severe osteoarthritis

Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse

JCM, Vol. 11, Pages 2388: Are EPA and DHA Derivatives Involved in IBD Remission?